Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 3,983 | 3,083 | 2,959 | 2,622 | 3,625 |
| Operating Income | -3,983 | -3,083 | -2,959 | -2,622 | -3,625 |
| Other Income | 30 | 31 | 42 | 47 | 43 |
| Pre-tax Income | -3,953 | -3,052 | -2,917 | -2,575 | -3,582 |
| Net Income Continuous | -3,953 | -3,052 | -2,917 | -2,575 | -3,582 |
| Net Income | $-3,953 | $-3,052 | $-2,917 | $-2,575 | $-3,582 |
| EPS Basic Total Ops | -3.48 | -3.24 | -1.68 | -2.76 | -3.84 |
| EPS Basic Continuous Ops | -2.95 | -3.21 | -1.66 | -2.71 | -3.76 |
| EPS Diluted Total Ops | -3.48 | -3.24 | -1.68 | -2.76 | -3.84 |
| EPS Diluted Continuous Ops | -2.95 | -3.21 | -1.66 | -2.71 | -3.76 |
| EBITDA(a) | $-3,981 | $-3,082 | $-2,957 | $-2,621 | $-3,625 |